Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
PRIME (Projet de recherche inter-instituts multi-équipes) interdisciplinary CNRS programme (http://www.cnrs.fr/mi ). The PhD candidate will be co-supervised by Florence Niedergang (Team « Biology of
-
cultures following established laboratory protocols Assist with preparation of collagen-based cellular constructs and microfluidic culture systems used for vascular biology experiments Follow established
-
are no longer sufficient to explore the vast chemical space of recycling streams. To overcome this, "AI-Powered Microfluidics" - the synergy between microscale fluidics and Artificial Intelligence - offers a
-
, hepatitis B virus, coronaviruses, and others. For more information, please visit our official website: https://cidr.westlake.edu.cn/en/ . We are seeking outstanding scientists to lead vigorous, independent
-
collaboration, we are building a high-throughput single-cell analysis platform that combines microfluidics, advanced imaging and AI-based analysis to study gut microbial consortia. You will drive the development
-
become part of the interdisciplinary BioMicroSystems group, led by Maria Nordin. The BioMicroSystems group focuses on using microtechnology and microfluidics to solve complex biological questions
-
strategies to stabilize these photonic structures through chemical modification and photo-crosslinking. Furthermore, you will study how spherical confinement — achieved through emulsion or microfluidic methods
-
microscopy - Perform single particle detection and spectroscopy in a microfluidic setup - Perform different microscopies including scanning electron microscopy (SEM), and optical microscopy (OM
-
Position: Postdoctoral Research Associate in Microfluidics for Quantum Bio-Sensing Salary: Grade 7 (£37,694 - £47,389) Contract: Full-Time (35 hours per week), Fixed Term for 24 months Holiday
-
our partners (F. Mallogi, K. Perez-Torralla, CEA Saclay) for the development of the microfluidic chip, work on the integration of primary patient cells and on the validation of the device based